阴蒂真空吸引与振动刺激治疗神经源性女性性高潮障碍的随机试验
该随机临床试验纳入31例多发性硬化(MS)或脊髓损伤(SCI)女性,比较阴蒂真空吸引装置(CVSD)与振动刺激(V)治疗性高潮障碍的安全性和疗效。结果显示CVSD在FSFI总分及多个维度显著改善并降低性困扰,V仅在高潮子量表显著改善;CVSD疗效维持至治疗后4周。
要点
- CVSD可显著改善MS/SCI女性性功能总分、欲望、唤起、润滑、高潮及满意度并降低困扰。
- 振动刺激仅显著改善FSFI高潮子量表,且疗效限于治疗期。
- 因可及性与成本,临床可考虑振动刺激;CVSD推荐用于多种性功能障碍或振动无效者。
核心结论
- CVSD治疗MS和SCI相关女性神经源性性功能障碍安全且总体有效。
- 振动刺激对神经源性性高潮障碍也安全有效,但结果仅限于积极治疗期。
研究设计与样本
- 随机临床试验,在两家学术医疗中心开展,共纳入31例女性(20例MS,11例SCI)。
- 干预为为期12周的CVSD与V使用比较。
主要发现
- CVSD组FSFI总分(P=.011)、欲望(P=.009)、唤起(P=.009)、润滑(P=.008)、高潮(P=.012)、满意度(P=.049)均显著提高,FSDS困扰显著降低(P=.020)。
- V组仅FSFI高潮子量表显著提高(P=.028)。
- CVSD组在治疗结束后4周维持改善。
关键数值与推荐
- 主要结局指标为女性性功能指数(FSFI)和女性性困扰量表(FSDS)。
- CVSD组FSFI总分P=.011,欲望P=.009,唤起P=.009,润滑P=.008,高潮P=.012,满意度P=.049;FSDS P=.020。
- V组FSFI高潮子量表P=.028。
临床怎么用
- 因可及性与成本,临床医生可考虑对MS或SCI伴性高潮障碍的女性使用振动刺激。
- CVSD推荐用于存在多种性功能障碍或振动刺激无效的女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the safety and efficacy of using a clitoral vacuum suction device (CVSD) versus vibratory stimulation (V) to treat orgasmic dysfunction in women with multiple sclerosis (MS) or spinal cord injury (SCI). DESIGN: Randomized clinical trial. SETTING: Two academic medical centers. PARTICIPANTS: Women (N=31) including 20 with MS and 11 with SCI. INTERVENTION: A 12-week trial of the use of a CVSD versus V. MAIN OUTCOME MEASURES: Female Sexual Function Inventory (FSFI) and Female Sexual Distress Scale (FSDS). RESULTS: Twenty-three women (18 MS, 5 SCI) completed the study including 13 of 16 randomized to CVSD and 10 of 15 randomized to V. There was a statistically significant increase in total FSFI score (P=.011), desire (P=.009), arousal (P=.009), lubrication (P=.008), orgasm (P=.012), and satisfaction (P=.049), and a significant decrease in distress as measured by FSDS (P=.020) in subjects using the CVSD. In subjects who used V, there was a statistically significant increase in the orgasm subscale of the FSFI (P=.028). Subjects using the CVSD maintained improvements 4 weeks after treatment. CONCLUSIONS: CVSD is safe and overall efficacious to treat female neurogenic sexual dysfunction related to MS and SCI. V is also safe and efficacious for female neurogenic orgasmic dysfunction; however, results were limited to the active treatment period. Because of ease of access and cost, clinicians can consider use of V for women with MS or SCI with orgasmic dysfunction. CVSD is recommended for women with multiple sexual dysfunctions or for whom V is ineffective.
引用
- Alexander M, Bashir K, Alexander C, et al. Randomized Trial of Clitoral Vacuum Suction Versus Vibratory Stimulation in Neurogenic Female Orgasmic Dysfunction. Arch Phys Med Rehabil. 2017. PMID: 28899827. doi:10.1016/j.apmr.2017.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。